DR. RONALD NATHANIEL MARCUS, MD
Psychiatric at Research Pkwy, Wallingford, CT

License number
Connecticut 026822
Category
Psychiatric
Type
Psychiatry
Address
Address 2
5 Research Pkwy, Wallingford, CT 06492
99 W Meadow Rd, New Haven, CT 06518
Phone
(203) 677-6763

Professional information

Ronald Nathaniel Marcus Photo 1

Ronald Nathaniel Marcus, Wallingford CT

Specialties:
Psychiatrist
Address:
5 Research Pkwy, Wallingford, CT 06492
Education:
State University of New York, School of Medicine and Biomedical Sciences (Buffalo) - Doctor of Medicine*
New York Presbyterian Hospital-Westchester Division - Fellowship - Research*
New York Presbyterian Hospital-Westchester Division - Residency - Psychiatry*
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)*


Ronald N Marcus Photo 2

Dr. Ronald N Marcus, Wallingford CT - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Psychiatry)
Address:
5 Research Pkwy, Wallingford 06492
(203) 677-6763 (Phone)
Certifications:
Psychiatry, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
State University of New York At Buffalo
Graduated: 1983
Nassau University Medical Center
Ny Hosp-Westchester Div


Ronald Marcus Photo 3

Nefazodone: Use In Treating Post Traumatic Stress Disorder

US Patent:
5852020, Dec 22, 1998
Filed:
Jul 31, 1997
Appl. No.:
8/904011
Inventors:
Ronald N. Marcus - Hamden CT
Brenda Martini - Hamden CT
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31449
US Classification:
514252
Abstract:
Nefazodone and its pharmaceutically acceptable salts are useful in alleviation of post traumatic stress disorder.


Ronald Marcus Photo 4

Nefazodone: Use In Migraine Prophylaxis

US Patent:
5854248, Dec 29, 1998
Filed:
Apr 10, 1997
Appl. No.:
8/843671
Inventors:
Ronald N. Marcus - Hamden CT
Neil M. Sussman - Hamden CT
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31495
US Classification:
514255
Abstract:
Nefazodone and its pharmaceutically acceptable salts are useful in prophylactic treatment of recurrent headache disorders, as, in particular, vascular and migraine headaches.